Can Zions Bancorporation (ZION) Stock Reach $72?

Zions Bancorporation, National Association (ZION) is a Salt Lake City–based regional bank serving commercial and small-to-midsize business customers across 11 western and southwestern states. After a third-quarter earnings beat in late 2026, investors are asking whether the shares can extend their recovery toward the $72 mark that anchors much of the current sell-side research. The short answer is that it is plausible but far from assured.

Key Takeaways

• The central $72 target is the arithmetic mean of current analyst price targets reviewed for this analysis, which cluster between roughly $62 and $80.
• With shares trading near $64.4, reaching $72 requires an upside of about 12%, a meaningful but not extreme move.
• The strongest supports are an improving net interest income (NII) outlook, solid credit quality, and a below-market valuation.
• The biggest risks are a revenue miss, net interest margin (NIM) pressure, and a wide gap between cautious and bullish analysts.
• Aggregate data aggregators report a broadly similar picture, with average targets near $71–$73 and a prevailing "Hold" rating.

Analyst Price Targets and Consensus View

This analysis reviewed a set of current, individually attributed price targets rather than relying on any single website's headline consensus. Recent targets include Baird at $80 (Outperform), D.A. Davidson at $80 (Buy), Cantor Fitzgerald at $76 (Overweight), Jefferies at $75 (Buy), Wells Fargo at $73 (Equal Weight), JPMorgan at $70 (Underweight), Piper Sandler at $68 (Neutral), Truist at $67, and Morgan Stanley at roughly $62. The arithmetic mean of these figures is about $72, which is the central target used here. The range is wide—roughly $62 to $80—reflecting genuine disagreement about Zions' earnings trajectory.

After third-quarter results, Baird's David George and D.A. Davidson's Peter Winter both raised targets to $80, citing encouraging guidance, while JPMorgan's Anthony Elian lifted his target to $70 but kept an Underweight rating. Jefferies trimmed its target to $75 while maintaining a Buy. Overall, the sell-side skew is cautious: most ratings are Hold, with a smaller cluster of Buy ratings and a handful of Sell or Underweight calls. The reasoning splits along two lines—bulls emphasize NII growth and cheap valuation, while skeptics point to revenue misses and NIM sensitivity to interest rates.

Current Market Position and Path Toward the Target

Zions shares rose about 2% to roughly $64.4 after the company's third-quarter report, which featured adjusted earnings per share (EPS) that beat expectations even as revenue of about $881 million missed consensus estimates. Reaching $72 from that level implies a gain of roughly 12%—a substantial move that is achievable in principle but requires a sustained positive catalyst rather than a single good quarter.

The path toward the target likely depends on whether the company can translate its guidance into actual NII growth. Management raised its near-term outlook, projecting NII growth of 8% to 12% in the coming quarter and suggesting NIM could climb toward the mid-3% range if the interest-rate path implied by the yield curve plays out. Net charge-offs remained remarkably low at an annualized 2 basis points of average loans, underscoring solid credit quality. Analysts also note the stock trades at a price-to-earnings (P/E) ratio around 8, a level that leaves room for multiple expansion if earnings momentum continues.

What Could Support a Move Toward the Target

• NII and NIM momentum: Zions' asset-sensitive balance sheet can benefit if interest rates stay elevated, supporting margin expansion and NII growth of 8% to 12%.
• Credit quality: Exceptionally low net charge-offs reduce the risk of a reserve-driven earnings hit.
• Valuation: A single-digit P/E and a low PEG ratio suggest the market is not pricing in much growth, leaving room for re-rating.
• Analyst revisions: Post-earnings target increases from Baird and D.A. Davidson signal improving sentiment, and favorable regional-bank conditions such as steady loan growth and deal activity could broaden support.

What Could Prevent the Target From Being Reached

• Revenue misses: Zions has missed revenue expectations on several occasions, and the latest quarter was no exception.
• Rate sensitivity: If the Federal Reserve cuts rates faster than expected, NIM compression could offset loan-growth benefits.
• Competition and funding costs: Rising deposit costs in a competitive environment could pressure profitability.
• Analyst skepticism: Underweight and Neutral ratings from firms like JPMorgan and Truist reflect doubts about whether current momentum can be sustained to justify higher prices.

Technical Levels and Market Structure

Zions trades in the middle of a 52-week range spanning roughly $48.50 to $73.34, after pulling back about 15% from its mid-2026 peak. The $70 level stands out as both a psychological threshold and an area of prior resistance, while the $73–$74 zone marks the recent high and a key hurdle before any test of $80. On the downside, support appears near $60, with deeper support around $57–$58. A sustained move above $70 would signal improving momentum toward the $72 target, whereas failure to hold $62 could suggest the recovery is fading.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a roughly 12-month research horizon, though individual analysts use differing timeframes and methodologies, so the $72 figure should not be read as a precise near-term forecast. Key items to monitor include upcoming quarterly earnings and NII guidance, the trajectory of the Federal Reserve's interest-rate policy, deposit-cost trends, credit metrics, and any further analyst target revisions. Regional-bank sentiment and merger-and-acquisition activity in the sector can also influence how Zions is valued relative to its target.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals from shifting market conditions, technical behavior, and AI-driven analysis. The tool helps traders surface new opportunities, track existing positions, and identify changing trends more efficiently than manual screening alone. For those following Zions' path toward higher price levels, this type of signal monitoring can add a data-driven layer to the analyst-target debate.

Final Assessment

The $72 central target—an average of current analyst price targets ranging from roughly $62 to $80—implies about a 12% move from the recent price near $64.4. The case for reaching it rests on NII growth of 8% to 12%, NIM expansion in a higher-rate environment, unusually strong credit quality, and a valuation that leaves room to run. The case against it rests on persistent revenue misses, rate-path uncertainty, and a genuinely divided analyst community whose cautious Hold and Underweight ratings temper the more bullish $80 targets. The gap between those views means $72 is a realistic benchmark to track, not a promise. Investors should weigh the improving earnings picture against the revenue and rate risks, and monitor the next earnings report, guidance, and analyst revisions closely.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations